FGF19 and type 2 diabetes mellitus: ROC curve analysis indicated that the inclusion of primary and secondary cBAs and FGF-19 improved model discrimination for T2DM (ΔAUC=0.03, 95% Confidence Interval: 0.01-0.06; Net Reclassification Improvement=0.54; 95%CI: 0.30-0.75).